subslover
2 weeks ago
The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest
FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc. (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa Clinic, P.C., one of the most highly regarded multispecialty healthcare groups in the United States. This deal positions The Iowa Clinic as one of Counterpart's anchor customers in the Midwest, as Counterpart drives a broader strategic expansion across the country. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”).
Founded in 1994, The Iowa Clinic is a benchmark for excellence in American healthcare, recognized as one of America's Top 100 Healthcare Providers by Becker's Hospital Review and a recipient of multiple Press Ganey Guardian of Excellence Awards for patient satisfaction. As the largest physician-owned multispecialty group in its community, with over 250 providers across more than 40 specialties, The Iowa Clinic is celebrated for its pioneering physician-governed, patient-centered model. It also has been recognized for its leadership in patient safety by the Leapfrog Group and quality care by the NCQA. The clinic is a frequent collaborator in national research and an early adopter of advanced diagnostic technologies, with its physicians regularly featured in Castle Connolly's list of America’s Top Doctors. Renowned for its clinical expertise and commitment to innovation, The Iowa Clinic consistently delivers world-class, patient-centered care.
Under the terms of the agreement, clinicians serving The Iowa Clinic’s Medicare Advantage and Medicare Shared Savings Program patients will use Counterpart Assistant, Counterpart Health’s cutting-edge cloud-based software platform. Additionally, the platform will be made available to The Iowa Clinic’s clinically integrated network partners throughout the Midwest. Counterpart will receive a per-member, per-month fee, as well as potential incentive payments contingent on achieving certain care management goals.
“Counterpart Assistant was engineered in one of the most challenging healthcare markets in the nation, attracting leading payors and provider groups dedicated to addressing the complex needs of patients in challenging markets,” said Andrew Toy, CEO of Clover Health. “The Iowa Clinic stands at the forefront of innovative, value-based care solutions, and we are confident our technology will deliver substantial clinical value to the hundreds of physicians within this distinguished provider group, as well as their Medicare patients.”
“We take great pride in being a leader in the adoption of innovative medical technologies and treatments, always with the aim of elevating the quality of care our patients receive,” said Ben Vallier, CEO of The Iowa Clinic, P.C. “Counterpart’s ability to harness clinical data to drive improved outcomes, combined with its intuitive design that understands the needs of practicing clinicians, stood out among other potential solutions, and makes it a perfect fit for our organization. We are very optimistic about the immediate and long-term clinical and financial value it will bring to our providers and patients alike.”
Built on technology originally developed by Clover Health, Counterpart Assistant is an AI-enabled solution designed to seamlessly integrate into physicians’ workflows, supporting earlier diagnosis and management of chronic diseases, and is currently used by over a thousand physicians as part of their daily workflow to enhance patient care. By leveraging real-time insights from more than a hundred data sources and utilizing over one hundred machine learning models, providers using Counterpart Assistant can identify, diagnose, and treat some of the most costly chronic diseases earlier. For example, Clover Health has seen over a 1,000 basis point medical cost ratio (MCR) differential between returning members of its Medicare Advantage plans whose primary care physicians (PCP) use Counterpart Assistant versus those members whose PCPs do not. As Counterpart’s largest customer, the success of Clover Health’s PPO-focused Medicare Advantage plans stand as a powerful testament to the value the technology can bring to plans and providers managing Medicare risk.
For companies interested in learning more about how Counterpart can reduce the total cost of care in value-based care models through advanced chronic disease management, visit www.counterparthealth.com.
About Counterpart Health
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI powered physician enablement platform. Counterpart Health’s flagship software platform, Counterpart Assistant, was incubated by Clover Health as Clover Assistant and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology. Counterpart Health extends the benefits of the data-driven technology platform outside of Clover Health’s Medicare Advantage plan to a wider audience, to enable enhanced patient outcomes and reduced healthcare costs nationwide. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
About The Iowa Clinic, P.C.
Formed in 1994, The Iowa Clinic is the largest independent, physician-owned multi-specialty group in the Des Moines community with more than 250 physicians and healthcare providers practicing in 40-plus specialties. The organiz
MadeMillions$
2 weeks ago
I’m actually hoping those who manipulate CLOV will push the price even lower. Many of you know I'm heavily vested in Clover Health, holding significant shares and options since my first buy in May 2021. It's been a wild ride, but the recent developments have been incredibly promising. Here’s why I’m embracing the possibility of CLOV being driven lower ahead of Q3:
Clover has already proven its concept with patented technology that stands out in the industry. The fact that larger insurers are facing challenges while we continue to improve demonstrates the competitive edge CLOV holds over established names in the Medicare Advantage space, such as Humana, UnitedHealth Group, and others. Humana has recently slashed profit projections due to unexpected rises in medical costs, while UnitedHealth Group has been dealing with legal battles over allegations of overbilling Medicare. These struggles highlight the growing pressures in the sector, yet Clover Health continues to show resilience and progress.
If the stock is pushed lower before our next earnings report and the update on our new SaaS revenue stream's profitability, it presents a strategic buying opportunity. Here’s a reminder of all CLOV has going for it following the last earnings report:
MadeMillions$
4 weeks ago
Ladies and gentlemen, we gather here today to reflect on a unique group of individuals: those who made the bold decision to short Clover Health stock. While their actions were driven by strategy, calculation, and perhaps a dash of skepticism, their journey became a testament to the unpredictable nature of markets and the complexities of betting against innovation.
These short-sellers embarked on their path with conviction, believing they had identified a weakness or a misstep in Clover Health’s trajectory. They combed through financials, analyzed market trends, and held firm in their belief that this company’s rise was unsustainable. In doing so, they played an essential role in keeping the market in balance, reminding us all that for every bull, there must be a bear.
But as time went on, and Clover Health showed resilience, adaptability, and growth, these short-sellers found themselves facing the harsh realities of a market that can often defy even the best-laid plans. What began as a calculated gamble became, for many, an expensive lesson in the power of innovation and perseverance. Clover Health didn’t falter the way they expected. Instead, it evolved, and with it, the fortunes of those betting against it changed.
In this reflection, we do not mourn their losses but celebrate their participation in the grand theater of the stock market, where risks are taken, lessons are learned, and the future remains unwritten. For every short-seller, there’s a story of ambition and belief, and today, we honor their place in that story.
May they find peace in the knowledge that in this dynamic, ever-shifting market, they played their part. And as Clover Health continues to rise, may we all remember the value of conviction – whether we stand with the bulls or the bears.
Rest easy, short-sellers. You gave it your all.
subslover
4 weeks ago
Thomas L. Tran, Former Chief Financial Officer of Molina Healthcare, Joins Clover Health’s Board of Directors
FRANKLIN, Tenn., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced it has appointed Thomas L. Tran to the Company’s Board of Directors (the "Board"), and as a member of the Audit Committee.
“Tom Tran’s appointment to our Board marks a significant enhancement to our strategic financial planning and execution capabilities. With his impressive track record at the helm of finance at public managed care organizations, Tom is uniquely qualified to help guide Clover Health as we advance our mission of empowering physicians and improving health outcomes through innovative technology,” said Andrew Toy, Chief Executive Officer of Clover Health.
Mr. Tran has over 35 years of financial leadership experience in the healthcare industry and has previously held leadership roles at various prominent managed care companies. Most recently, from February 2022 to June 2023, Mr. Tran served as chief financial officer and as a director of Upstream Care, a value-based physician enablement innovator focused on the Medicare population. From June 2018 to May 2021, he served as chief financial officer of Molina Healthcare, Inc. Mr. Tran earned his Bachelor’s degree from Seton Hall University and his Master of Business Administration degree from New York University.
“Having dedicated my career to improving healthcare through better financial and operational strategies, I find Clover Health's mission very compelling. I believe Clover’s innovative use of technology to drive better health outcomes represents the future of Medicare. I am excited to join the Board and help shape this vision, ensuring Clover continues to lead in value-based care,” said Mr. Tran.
subslover
4 weeks ago
Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 4:30 p.m. Eastern Time.
A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
ollik78
5 days ago
Jimmy Joe
2 weeks ago
glenn1919
2 weeks ago
gail
4 weeks ago
Spuds McKenz66
1 month ago
